ADIPOQ and airway hyperresponsiveness: Perhaps activating the TRPV4 channel on adipocytes or immune cells can reduce the secretion of leptin and adiponectin, prevent the content of adipocytokines in the surrounding blood, inhibit the occurrence of airway hyperresponsiveness, and ultimately achieve the goal of controlling asthma.